- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/08 - Virus à ARN
Détention brevets de la classe C07K 14/08
Brevets de cette classe: 467
Historique des publications depuis 10 ans
10
|
22
|
34
|
27
|
29
|
31
|
38
|
48
|
36
|
13
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Medicago Inc. | 203 |
9 |
Regents of the University of Minnesota | 2620 |
8 |
University of Manitoba | 446 |
8 |
Realta Holdings, LLC | 24 |
8 |
Folia Biotech Inc. | 10 |
7 |
The Regents of the University of California | 18943 |
6 |
Children's Hospital Medical Center | 690 |
6 |
Boehringer Ingelheim Vetmedica GmbH | 1290 |
5 |
The Trustees of Columbia University in the City of New York | 3440 |
5 |
Elanco US Inc. | 698 |
5 |
The Scripps Research Institute | 1364 |
5 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
5 |
Pfizer Inc. | 3322 |
4 |
Centre National de La Recherche Scientifique | 9632 |
4 |
The Trustees of the University of Pennsylvania | 4122 |
4 |
Duke University | 2872 |
4 |
Denka Company Limited | 2189 |
4 |
Intervet Inc. | 848 |
4 |
Intervet International B.V. | 1235 |
4 |
Zoetis Services LLC | 1537 |
4 |
Autres propriétaires | 358 |